Showing results (51-60 of 160) with videos related to
Sort By:
Pageof 16
Diabetes, Obesity & Metabolism|January 22, 2019
Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: Individual effects of treatmentEmilie H Zobel, Bernt J von Scholten, Bryan Goldman, et al.Redox Biology|July 1, 2017
Urinary albumin and 8-oxo-7,8-dihydroguanosine as markers of mortality and cardiovascular disease during 19 years after diagnosis of type 2 diabetes - A comparative study of two markers to identify high risk patientsKasper Broedbaek, Rasmus Køster-Rasmussen, Volkert Siersma, et al.Diabetes, Obesity & Metabolism|March 5, 2023
Sotagliflozin, a dual sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetesElisabeth B Stougaard, Peter Rossing, Dorte Vistisen, et al.Diabetes, Obesity & Metabolism|October 19, 2016
The effect of liraglutide on renal function: A randomized clinical trialBernt J von Scholten, Frederik Persson, Signe Rosenlund, et al.Journal of Diabetes and Its Complications|August 14, 2022
Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetesHenrik Ø Hjortkjær, Frederik Persson, Simone Theilade, et al.Diabetes|November 30, 2006
Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudyFrederik Persson, Peter Rossing, Peter Hovind, et al.BMJ Open|September 21, 2024
Cohort profile: the PRIMETIME 1 (PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy) cohort - a longitudinal Danish nationwide study of individuals with diabetes and a performed kidney biopsyKarina Haar Jensen, Vanja Kosjerina, Ditte Hansen, et al.BMJ Open Diabetes Research & Care|May 26, 2026
Mapping shared genetic determinants of eGFR and albuminuria with a focus on type 2 diabetes: a large-scale European studyCilia Naaman, Frederik Persson, Thomas Kümler, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 17, 2018
Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetesSascha Pilemann-Lyberg, Tine Willum Hansen, Frederik Persson, et al.Diabetes, Obesity & Metabolism|February 3, 2022
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrologySimke W Waijer, Michele Provenzano, Skander Mulder, et al.Pageof 16